StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.37−0.03 (-2.14%)

Close on Nov 18, 2026Market cap $87.31MP/E –Yield –

TuHURA Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

TuHURA Biosciences's total debt was $5 at Mar 31, 2018. For fiscal 2017 it was $33.09K, down 95.2% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2017Jun 30, 2017$33.09K-95.2%
FY2016Jun 30, 2016$693.70K–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2018CQ1 2018Mar 31, 2018$5-100.0%
Q2 FY2018CQ4 2017Dec 31, 2017$95-99.9%
Q1 FY2018CQ3 2017Sep 30, 2017$589-99.9%
Q4 FY2017CQ2 2017Jun 30, 2017$33.09K-96.7%
Q3 FY2017CQ1 2017Mar 31, 2017$248.69K-81.6%
Q2 FY2017CQ4 2016Dec 31, 2016$171.21K–
Q4 FY2016CQ2 2016Jun 30, 2016$693.70K–
Q3 FY2016CQ1 2016Mar 31, 2016$1.02M–
Q2 FY2016CQ4 2015Dec 31, 2015$1.35M–

More TuHURA Biosciences figures

See a number that looks wrong?